On the public citation graph

Highly pathogenic coronavirus N protein aggravates inflammation by MASP-2-mediated lectin complement pathway overactivation

https://doi.org/10.1101/2020.03.29.20041962
0 signed · 518 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1007/s11427-020-1643-8openalex-snapshot
Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury
inferredcites →https://doi.org/10.1016/j.antiviral.2013.08.015openalex-snapshot
From SARS to MERS: 10 years of research on highly pathogenic human coronaviruses
inferredcites →https://doi.org/10.1016/j.bbapap.2011.05.021openalex-snapshot
Mannose-binding lectin serine proteases and associated proteins of the lectin pathway of complement: Two genes, five proteins and many functions?
inferredcites →https://doi.org/10.1016/j.ccm.2004.10.014openalex-snapshot
Acute Lung Injury and Bacterial Infection
inferredcites →https://doi.org/10.1016/j.cell.2021.12.040openalex-snapshot
Complement activation induces excessive T cell cytotoxicity in severe COVID-19
inferredcites →https://doi.org/10.1016/j.chom.2017.11.009openalex-snapshot
Leukotriene B4-Mediated Neutrophil Recruitment Causes Pulmonary Capillaritis during Lethal Fungal Sepsis
inferredcites →https://doi.org/10.1016/j.clim.2020.108555openalex-snapshot
Anti-complement C5 therapy with eculizumab in three cases of critical COVID-19
inferredcites →https://doi.org/10.1016/j.coi.2005.11.014openalex-snapshot
The mannose-binding lectin: a prototypic pattern recognition molecule
inferredcites →https://doi.org/10.1016/j.imbio.2006.11.004openalex-snapshot
Interactions between mannose-binding lectin and MASPs during complement activation by the lectin pathway
inferredcites →https://doi.org/10.1016/j.imbio.2020.152001openalex-snapshot
Endothelial injury and thrombotic microangiopathy in COVID-19: Treatment with the lectin-pathway inhibitor narsoplimab
inferredcites →https://doi.org/10.1016/j.immuni.2021.04.009openalex-snapshot
CD8+ T cells specific for an immunodominant SARS-CoV-2 nucleocapsid epitope display high naive precursor frequency and TCR promiscuity
inferredcites →https://doi.org/10.1016/j.jim.2011.08.006openalex-snapshot
MAp19, the alternative splice product of the MASP2 gene
inferredcites →https://doi.org/10.1016/j.jim.2014.09.002openalex-snapshot
Quantification of complement system activation by measuring C5b-9 cell surface deposition using a cell-ELISA technique
inferredcites →https://doi.org/10.1016/j.molimm.2004.06.015openalex-snapshot
Mannose binding lectin (MBL) and HIV
inferredcites →https://doi.org/10.1016/j.molimm.2008.05.020openalex-snapshot
Complement activation by PEGylated single-walled carbon nanotubes is independent of C1q and alternative pathway turnover
inferredcites →https://doi.org/10.1016/j.molimm.2009.04.026openalex-snapshot
Early complement proteases: C1r, C1s and MASPs. A structural insight into activation and functions
inferredcites →https://doi.org/10.1016/j.molimm.2013.05.007openalex-snapshot
Toward a structure-based comprehension of the lectin pathway of complement
inferredcites →https://doi.org/10.1016/j.molmed.2008.09.009openalex-snapshot
C1, MBL–MASPs and C1-inhibitor: novel approaches for targeting complement-mediated inflammation
inferredcites →https://doi.org/10.1016/j.thromres.2020.06.027openalex-snapshot
Is COVID-19 associated thrombosis caused by overactivation of the complement cascade? A literature review
inferredcites →https://doi.org/10.1016/j.tim.2010.03.007openalex-snapshot
Haemophilus influenzae and the complement system
inferredcites →https://doi.org/10.1016/j.trsl.2020.04.007openalex-snapshot
Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: A report of five cases
inferredcites →https://doi.org/10.1016/j.trsl.2020.11.008openalex-snapshot
The role of the lectin pathway of the complement system in SARS-CoV-2 lung injury
inferredcites →https://doi.org/10.1016/s0022-1759(01)00453-7openalex-snapshot
An assay for the mannan-binding lectin pathway of complement activation
inferredcites →https://doi.org/10.1016/s0140-6736(03)13376-4openalex-snapshot
A multicentre collaboration to investigate the cause of severe acute respiratory syndrome
inferredcites →https://doi.org/10.1016/s2665-9913(20)30341-6openalex-snapshot
Anti-C5a antibody IFX-1 (vilobelimab) treatment versus best supportive care for patients with severe COVID-19 (PANAMO): an exploratory, open-label, phase 2 randomised controlled trial
inferredcites →https://doi.org/10.1038/cr.2009.139openalex-snapshot
Complement and its role in innate and adaptive immune responses
inferredcites →https://doi.org/10.1038/ncomms7833openalex-snapshot
Recovery from severe H7N9 disease is associated with diverse response mechanisms dominated by CD8+ T cells
inferredcites →https://doi.org/10.1038/nri2620openalex-snapshot
Complement regulators and inhibitory proteins
inferredcites →https://doi.org/10.1038/nrmicro3143openalex-snapshot
A decade after SARS: strategies for controlling emerging coronaviruses
inferredcites →https://doi.org/10.1038/s41426-018-0063-8openalex-snapshot
Blockade of the C5a–C5aR axis alleviates lung damage in hDPP4 -transgenic mice infected with MERS-CoV
inferredcites →https://doi.org/10.1038/s41467-021-23036-9openalex-snapshot
A SARS-CoV-2 antibody curbs viral nucleocapsid protein-induced complement hyperactivation
inferredcites →https://doi.org/10.1038/s41467-022-29948-4openalex-snapshot
Ebola virus VP35 hijacks the PKA-CREB1 pathway for replication and pathogenesis by AKIP1 association
inferredcites →https://doi.org/10.1038/s41577-020-0320-7openalex-snapshot
Complement as a target in COVID-19?
inferredcites →https://doi.org/10.1038/s41577-021-00665-1openalex-snapshot
The state of complement in COVID-19
inferredcites →https://doi.org/10.1038/s41581-020-00357-4openalex-snapshot
Immunity, endothelial injury and complement-induced coagulopathy in COVID-19
inferredcites →https://doi.org/10.1038/s41586-020-2012-7openalex-snapshot
A pneumonia outbreak associated with a new coronavirus of probable bat origin
inferredcites →https://doi.org/10.1038/s41586-020-2286-9openalex-snapshot
A SARS-CoV-2 protein interaction map reveals targets for drug repurposing
inferredcites →https://doi.org/10.1038/s41586-020-2600-6openalex-snapshot
Association of COVID-19 inflammation with activation of the C5a–C5aR1 axis
inferredcites →https://doi.org/10.1038/s41590-021-01114-wopenalex-snapshot
Recognition and inhibition of SARS-CoV-2 by humoral innate immunity pattern recognition molecules
inferredcites →https://doi.org/10.1038/s41598-021-92220-0openalex-snapshot
Secondary bacterial infection in COVID-19 patients is a stronger predictor for death compared to influenza patients
inferredcites →https://doi.org/10.1042/cs20020362openalex-snapshot
Beyond lysis: how complement influences cell fate
inferredcites →https://doi.org/10.1056/nejmoa030685openalex-snapshot
A Major Outbreak of Severe Acute Respiratory Syndrome in Hong Kong
inferredcites →https://doi.org/10.1056/nejmoa030747openalex-snapshot
Identification of a Novel Coronavirus in Patients with Severe Acute Respiratory Syndrome
inferredcites →https://doi.org/10.1073/pnas.0407992101openalex-snapshot
Plasma proteome of severe acute respiratory syndrome analyzed by two-dimensional gel electrophoresis and mass spectrometry
inferredcites →https://doi.org/10.1073/pnas.1101748108openalex-snapshot
Targeting of mannan-binding lectin-associated serine protease-2 confers protection from myocardial and gastrointestinal ischemia/reperfusion injury
inferredcites →https://doi.org/10.1073/pnas.2010540117openalex-snapshot
Systemic complement activation is associated with respiratory failure in COVID-19 hospitalized patients
inferredcites →https://doi.org/10.1073/pnas.80.21.6647openalex-snapshot
Consequences of cell membrane attack by complement: release of arachidonate and formation of inflammatory derivatives.
inferredcites →https://doi.org/10.1074/jbc.m506051200openalex-snapshot
A True Autoactivating Enzyme
inferredcites →https://doi.org/10.1074/jbc.m707591200openalex-snapshot
Activation of Complement Component C5
inferredcites →https://doi.org/10.1086/429631openalex-snapshot
Mannose-Binding Lectin in Severe Acute Respiratory Syndrome Coronavirus Infection
inferredcites →https://doi.org/10.1093/cvr/cvn277openalex-snapshot
Leukotriene B4 enhances the activity of nuclear factor- B pathway through BLT1 and BLT2 receptors in atherosclerosis
inferredcites →https://doi.org/10.1093/infdis/jit504openalex-snapshot
Active Replication of Middle East Respiratory Syndrome Coronavirus and Aberrant Induction of Inflammatory Cytokines and Chemokines in Human Macrophages: Implications for Pathogenesis
inferredcites →https://doi.org/10.1101/2020.03.29.20041962openalex-snapshot
Highly pathogenic coronavirus N protein aggravates inflammation by MASP-2-mediated lectin complement pathway overactivation
inferredcites →https://doi.org/10.1111/cts.13213openalex-snapshot
The anti‐C5a antibody vilobelimab efficiently inhibits C5a in patients with severe COVID‐19
inferredcites →https://doi.org/10.1111/j.1348-0421.2008.00011.xopenalex-snapshot
Co‐infection of respiratory bacterium with severe acute respiratory syndrome coronavirus induces an exacerbated pneumonia in mice
inferredcites →https://doi.org/10.1126/science.1085952openalex-snapshot
Characterization of a Novel Coronavirus Associated with Severe Acute Respiratory Syndrome
inferredcites →https://doi.org/10.1126/sciimmunol.aan5393openalex-snapshot
Recovery from the Middle East respiratory syndrome is associated with antibody and T cell responses
inferredcites →https://doi.org/10.1128/cmr.00102-14openalex-snapshot
Middle East Respiratory Syndrome Coronavirus: Another Zoonotic Betacoronavirus Causing SARS-Like Disease
inferredcites →https://doi.org/10.1128/iai.68.7.3894-3899.2000openalex-snapshot
The Lipopolysaccharide Structures ofSalmonella entericaSerovar Typhimurium andNeisseria gonorrhoeaeDetermine the Attachment of Human Mannose-Binding Lectin to Intact Organisms
inferredcites →https://doi.org/10.1128/iai.73.10.6868-6876.2005openalex-snapshot
Poly- N -Acetylglucosamine Production in Staphylococcus aureus Is Essential for Virulence in Murine Models of Systemic Infection
inferredcites →https://doi.org/10.1128/jvi.00133-08openalex-snapshot
The Nucleocapsid Protein of Severe Acute Respiratory Syndrome Coronavirus Inhibits Cell Cytokinesis and Proliferation by Interacting with Translation Elongation Factor 1α
inferredcites →https://doi.org/10.1128/jvi.00554-10openalex-snapshot
A Single Asparagine-Linked Glycosylation Site of the Severe Acute Respiratory Syndrome Coronavirus Spike Glycoprotein Facilitates Inhibition by Mannose-Binding Lectin through Multiple Mechanisms
inferredcites →https://doi.org/10.1128/jvi.01505-14openalex-snapshot
Virus-Specific Memory CD8 T Cells Provide Substantial Protection from Lethal Severe Acute Respiratory Syndrome Coronavirus Infection
inferredcites →https://doi.org/10.1128/jvi.79.17.11476-11486.2005openalex-snapshot
The Severe Acute Respiratory Syndrome Coronavirus Nucleocapsid Protein Is Phosphorylated and Localizes in the Cytoplasm by 14-3-3-Mediated Translocation
inferredcites →https://doi.org/10.1165/rcmb.2012-0428ocopenalex-snapshot
Inhibition of Complement Activation Alleviates Acute Lung Injury Induced by Highly Pathogenic Avian Influenza H5N1 Virus Infection
inferredcites →https://doi.org/10.1186/s12866-018-1314-5openalex-snapshot
Development of flow cytometric opsonophagocytosis and antibody-mediated complement deposition assays for non-typeable Haemophilus influenzae
inferredcites →https://doi.org/10.1371/journal.pmed.0030525openalex-snapshot
Vaccine Efficacy in Senescent Mice Challenged with Recombinant SARS-CoV Bearing Epidemic and Zoonotic Spike Variants
inferredcites →https://doi.org/10.1371/journal.pone.0047245openalex-snapshot
Functional Analyses of Complement Convertases Using C3 and C5-Depleted Sera
inferredcites →https://doi.org/10.1373/clinchem.2005.061689openalex-snapshot
Serum Proteomic Fingerprints of Adult Patients with Severe Acute Respiratory Syndrome
inferredcites →https://doi.org/10.1513/pats.200704-046awopenalex-snapshot
Complement Activation Pathways: A Bridge between Innate and Adaptive Immune Responses in Asthma
inferredcites →https://doi.org/10.2139/ssrn.3866835openalex-snapshot
Complement Activation Induces Excessive T Cell Cytotoxicity in Severe COVID-19
inferredcites →https://doi.org/10.3201/eid1011.040516openalex-snapshot
Nucleocapsid Protein as Early Diagnostic Marker for SARS
inferredcites →https://doi.org/10.3389/fimmu.2020.01949openalex-snapshot
Overview of Immune Response During SARS-CoV-2 Infection: Lessons From the Past
inferredcites →https://doi.org/10.3389/fimmu.2020.594849openalex-snapshot
Complement Activation in Kidneys of Patients With COVID-19
inferredcites →https://doi.org/10.3389/fimmu.2021.714511openalex-snapshot
Lectin Pathway Mediates Complement Activation by SARS-CoV-2 Proteins
inferredcites →https://doi.org/10.3389/fimmu.2022.821664openalex-snapshot
Characterization of Two Heterogeneous Lethal Mouse-Adapted SARS-CoV-2 Variants Recapitulating Representative Aspects of Human COVID-19
inferredcites →https://doi.org/10.4049/jimmunol.137.4.1286openalex-snapshot
Noncytolytic terminal complement complexes may serve as calcium gates to elicit leukotriene B4 generation in human polymorphonuclear leukocytes.
inferredcites →https://doi.org/10.4049/jimmunol.166.8.5068openalex-snapshot
Interaction Properties of Human Mannan-Binding Lectin (MBL)-Associated Serine Proteases-1 and -2, MBL-Associated Protein 19, and MBL
inferredcites →https://doi.org/10.4049/jimmunol.170.3.1374openalex-snapshot
Natural Substrates and Inhibitors of Mannan-Binding Lectin-Associated Serine Protease-1 and -2: A Study on Recombinant Catalytic Fragments
inferredcites →https://doi.org/10.4049/jimmunol.181.9.6337openalex-snapshot
Prior Immunization with Severe Acute Respiratory Syndrome (SARS)-Associated Coronavirus (SARS-CoV) Nucleocapsid Protein Causes Severe Pneumonia in Mice Infected with SARS-CoV

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.2139/ssrn.3626907openalex-extracted
inferred← citeshttps://doi.org/10.2139/ssrn.3755292openalex-extracted
Are Aspirin and Apixaban Sufficient to Prevent Immunothrombosis in COVID-19?
inferred← citeshttps://doi.org/10.2139/ssrn.3864027openalex-extracted
SARS-CoV-2 Spike Protein 1 Activates Microvascular Endothelial Cells and Complement System Leading to Thrombus Formation
inferred← citeshttps://doi.org/10.2139/ssrn.3866835openalex-extracted
Complement Activation Induces Excessive T Cell Cytotoxicity in Severe COVID-19
inferred← citeshttps://doi.org/10.2139/ssrn.3941802openalex-extracted
Antigenemia Is Associated to Viral Sepsis and Mortality in COVID-19
inferred← citeshttps://doi.org/10.2139/ssrn.4052956openalex-extracted
inferred← citeshttps://doi.org/10.1001/jamanetworkopen.2023.1713openalex-snapshot
Levels of Complement Components in Children With Acute COVID-19 or Multisystem Inflammatory Syndrome
inferred← citeshttps://doi.org/10.1002/advs.202504690openalex-snapshot
Engineered Dual‐Function Antibody‐Like Proteins to Combat SARS‐CoV‐2‐Induced Immune Dysregulation and Inflammation
inferred← citeshttps://doi.org/10.1002/cbin.11517openalex-snapshot
Dysregulation of the immune response in coronavirus disease 2019
inferred← citeshttps://doi.org/10.1002/eji.202048858openalex-snapshot
Deregulated cellular circuits driving immunoglobulins and complement consumption associate with the severity of COVID‐19 patients
inferred← citeshttps://doi.org/10.1002/eji.202048959openalex-snapshot
Complement cascade in severe forms of COVID‐19: Recent advances in therapy
inferred← citeshttps://doi.org/10.1002/eji.202350814openalex-snapshot
The complement system: A key player in the host response to infections
inferred← citeshttps://doi.org/10.1002/jcla.24941openalex-snapshot
Coagulopathy and thromboembolic events a pathogenic mechanism of COVID‐19 associated with mortality: An updated review
inferred← citeshttps://doi.org/10.1002/jlb.4covr0920-552rropenalex-snapshot
Identification of key signaling pathways induced by SARS-CoV2 that underlie thrombosis and vascular injury in COVID-19 patients
inferred← citeshttps://doi.org/10.1002/jmv.27077openalex-snapshot
Complement levels at admission as a reflection of coronavirus disease 2019 (COVID‐19) severity state
inferred← citeshttps://doi.org/10.1002/jmv.28311openalex-snapshot
Pathogenesis and histological changes of nephropathy associated with COVID‐19
inferred← citeshttps://doi.org/10.1002/jmv.28946openalex-snapshot
New‐onset and relapsed thrombotic microangiopathy post‐COVID‐19 vaccination
inferred← citeshttps://doi.org/10.1002/jmv.70751openalex-snapshot
Albendazole Suppresses SARS‐CoV‐2 Replication by Enhancing HERC5‐Mediated ISGylation of Nucleocapsid Protein
inferred← citeshttps://doi.org/10.1002/path.5642openalex-snapshot
COVID ‐19: immunopathology, pathophysiological mechanisms, and treatment options
inferred← citeshttps://doi.org/10.1002/ptr.8302openalex-snapshot
Phytoconstituents as modulator of inflammatory pathways for COVID ‐19: A comprehensive review and recommendations
inferred← citeshttps://doi.org/10.1002/rmv.2316openalex-snapshot
Complement inhibition: A possible therapeutic approach in the fight against Covid‐19
inferred← citeshttps://doi.org/10.1002/rmv.2431openalex-snapshot
SARS‐CoV‐2 nucleocapsid: Biological functions and implication for disease diagnosis and vaccine design
inferred← citeshttps://doi.org/10.1007/978-3-030-67048-1_2openalex-snapshot
Mannose-Binding Lectin in Human Health and Disease
inferred← citeshttps://doi.org/10.1007/978-3-030-67452-6_6openalex-snapshot
SARS-CoV-2: Pathogenic Mechanisms and Host Immune Response
inferred← citeshttps://doi.org/10.1007/978-3-030-70115-4_12openalex-snapshot
The Importance of Glycosylation in COVID-19 Infection
inferred← citeshttps://doi.org/10.1007/978-3-030-71697-4_8openalex-snapshot
SARS-CoV-2 Infection and the Kidneys: An Evolving Picture
inferred← citeshttps://doi.org/10.1007/978-3-030-90065-6_9openalex-snapshot
Thrombosis in CoViD19
inferred← citeshttps://doi.org/10.1007/s00018-024-05157-8openalex-snapshot
Emerging role of complement in COVID-19 and other respiratory virus diseases
inferred← citeshttps://doi.org/10.1007/s00109-020-01961-4openalex-snapshot
Immuno-epidemiology and pathophysiology of coronavirus disease 2019 (COVID-19)
inferred← citeshttps://doi.org/10.1007/s00277-020-04183-3openalex-snapshot
Thrombocytopenia in COVID-19: pathophysiology matters
inferred← citeshttps://doi.org/10.1007/s00284-021-02657-9openalex-snapshot
Molecular Insights into the Crosstalk Between Immune Inflammation Nexus and SARS-CoV-2 Virus
inferred← citeshttps://doi.org/10.1007/s00404-021-06061-3openalex-snapshot
Immunological and physiopathological approach of COVID-19 in pregnancy
inferred← citeshttps://doi.org/10.1007/s00430-021-00704-7openalex-snapshot
An update: the emerging evidence of complement involvement in COVID-19
inferred← citeshttps://doi.org/10.1007/s00430-021-00725-2openalex-snapshot
Persistently elevated complement alternative pathway biomarkers in COVID-19 correlate with hypoxemia and predict in-hospital mortality
inferred← citeshttps://doi.org/10.1007/s00438-023-02030-4openalex-snapshot
Mannose-binding lectin gene 2 variant DD (rs 5030737) is associated with susceptibility to COVID-19 infection in the urban population of Patna City (India)
inferred← citeshttps://doi.org/10.1007/s00441-024-03881-yopenalex-snapshot
Challenges of mesenchymal stem cells in the clinical treatment of COVID-19
inferred← citeshttps://doi.org/10.1007/s10719-021-10021-zopenalex-snapshot
SARS-CoV-2 S glycoprotein binding to multiple host receptors enables cell entry and infection
inferred← citeshttps://doi.org/10.1007/s10735-020-09915-3openalex-snapshot
COVID-19 and multiorgan failure: A narrative review on potential mechanisms
inferred← citeshttps://doi.org/10.1007/s10875-021-01061-zopenalex-snapshot
Elevated Expression Levels of Lung Complement Anaphylatoxin, Neutrophil Chemoattractant Chemokine IL-8, and RANTES in MERS-CoV-Infected Patients: Predictive Biomarkers for Disease Severity and Mortality
inferred← citeshttps://doi.org/10.1007/s11010-021-04107-3openalex-snapshot
Status of mannose-binding lectin (MBL) and complement system in COVID-19 patients and therapeutic applications of antiviral plant MBLs
inferred← citeshttps://doi.org/10.1007/s11033-021-06333-wopenalex-snapshot
COVID-19: imbalance of multiple systems during infection and importance of therapeutic choice and dosing of cardiac and anti-coagulant therapies
inferred← citeshttps://doi.org/10.1007/s11033-025-11189-5openalex-snapshot
Heterologous immunity and antibody-dependent enhancement in respiratory virus infections
inferred← citeshttps://doi.org/10.1007/s11239-020-02210-8openalex-snapshot
COVID-19: Are we dealing with a multisystem vasculopathy in disguise of a viral infection?
inferred← citeshttps://doi.org/10.1007/s11239-020-02297-zopenalex-snapshot
Coagulopathy, endothelial dysfunction, thrombotic microangiopathy and complement activation: potential role of complement system inhibition in COVID-19
inferred← citeshttps://doi.org/10.1007/s11239-021-02617-xopenalex-snapshot
Complement system component dysregulation is a distinctive feature of COVID-19 disease: a prospective and comparative analysis of patients admitted to the emergency department for suspected COVID-19 disease
inferred← citeshttps://doi.org/10.1007/s12015-021-10129-7openalex-snapshot
P2Y14 Receptor as a Target for Neutrophilia Attenuation in Severe COVID-19 Cases: From Hematopoietic Stem Cell Recruitment and Chemotaxis to Thrombo‐inflammation
inferred← citeshttps://doi.org/10.1007/s12031-022-02068-wopenalex-snapshot
Discovering Common Pathogenic Mechanisms of COVID-19 and Parkinson Disease: An Integrated Bioinformatics Analysis
inferred← citeshttps://doi.org/10.1007/s12079-021-00613-7openalex-snapshot
Is the mechanism of COVID-19 coagulopathy still a rabbit’s hole?
inferred← citeshttps://doi.org/10.1007/s13205-020-02464-2openalex-snapshot
Targeting complement cascade: an alternative strategy for COVID-19
inferred← citeshttps://doi.org/10.1007/s13337-021-00710-6openalex-snapshot
Patients with Covid 19 have significantly reduced CH50 activity
inferred← citeshttps://doi.org/10.1007/s13340-024-00746-1openalex-snapshot
Role of the receptor for advanced glycation end products in the severity of SARS-CoV-2 infection in diabetic patients
inferred← citeshttps://doi.org/10.1007/s40620-021-01125-8openalex-snapshot
COVID-19-associated atypical hemolytic uremic syndrome and use of Eculizumab therapy
inferred← citeshttps://doi.org/10.1007/s41745-021-00268-8openalex-snapshot
Neutralizing Antibodies and Antibody-Dependent Enhancement in COVID-19: A Perspective
inferred← citeshttps://doi.org/10.1007/s42399-021-00877-5openalex-snapshot
Portal Vein Thrombosis—a Rare Complication of SARS-CoV-2 Infection
inferred← citeshttps://doi.org/10.1007/s42977-023-00153-8openalex-snapshot
How much (evil) intelligence can be encoded by 30 kb?
inferred← citeshttps://doi.org/10.1016/b978-0-323-95374-0.00014-2openalex-snapshot
Understanding the molecular basis of pathogenesis of SARS-CoV-2
inferred← citeshttps://doi.org/10.1016/b978-0-443-15717-2.00008-1openalex-snapshot
COVID-19-Induced Vascular Coagulopathy
inferred← citeshttps://doi.org/10.1016/b978-0-443-18566-3.00037-2openalex-snapshot
Humoral immunity and thrombosis in COVID-19
inferred← citeshttps://doi.org/10.1016/bs.pmbts.2025.02.001openalex-snapshot
More antibodies are not always better: Fc effector functions play a critical role in SARS-CoV-2 infection and protection
inferred← citeshttps://doi.org/10.1016/j.addr.2021.113848openalex-snapshot
Drug delivery systems as immunomodulators for therapy of infectious disease: Relevance to COVID-19
inferred← citeshttps://doi.org/10.1016/j.ajpath.2021.05.007openalex-snapshot
COVID-19 Vasculopathy: Mounting Evidence for an Indirect Mechanism of Endothelial Injury
inferred← citeshttps://doi.org/10.1016/j.arr.2024.102636openalex-snapshot
The activation of microglia by the complement system in neurodegenerative diseases
inferred← citeshttps://doi.org/10.1016/j.atherosclerosis.2021.02.009openalex-snapshot
Coronavirus disease-19: The multi-level, multi-faceted vasculopathy
inferred← citeshttps://doi.org/10.1016/j.autrev.2021.102899openalex-snapshot
Similarities between COVID-19 and systemic sclerosis early vasculopathy: A “viral” challenge for future research in scleroderma
inferred← citeshttps://doi.org/10.1016/j.autrev.2022.103206openalex-snapshot
COVID-19 and the antiphospholipid syndrome
inferred← citeshttps://doi.org/10.1016/j.bbrc.2020.09.131openalex-snapshot
High-resolution structure and biophysical characterization of the nucleocapsid phosphoprotein dimerization domain from the Covid-19 severe acute respiratory syndrome coronavirus 2
inferred← citeshttps://doi.org/10.1016/j.berh.2021.101661openalex-snapshot
The interplay between neutrophils, complement, and microthrombi in COVID-19
inferred← citeshttps://doi.org/10.1016/j.biopha.2021.111234openalex-snapshot
Artesunate: A natural product-based immunomodulator involved in human complement
inferred← citeshttps://doi.org/10.1016/j.cell.2021.12.040openalex-snapshot
Complement activation induces excessive T cell cytotoxicity in severe COVID-19
inferred← citeshttps://doi.org/10.1016/j.celrep.2025.115512openalex-snapshot
Transfer of SARS-CoV-2 nucleocapsid protein to uninfected epithelial cells induces antibody-mediated complement deposition
inferred← citeshttps://doi.org/10.1016/j.celrep.2026.117613openalex-snapshot
Type I unconventional protein secretion of the SARS-CoV-2 nucleocapsid protein promotes inflammatory cytokine release
inferred← citeshttps://doi.org/10.1016/j.cels.2023.11.001openalex-snapshot
HOGVAX: Exploiting epitope overlaps to maximize population coverage in vaccine design with application to SARS-CoV-2
inferred← citeshttps://doi.org/10.1016/j.chom.2020.05.009openalex-snapshot
The Innate Immune System: Fighting on the Front Lines or Fanning the Flames of COVID-19?
inferred← citeshttps://doi.org/10.1016/j.clim.2020.108450openalex-snapshot
The first case of COVID-19 treated with the complement C3 inhibitor AMY-101
inferred← citeshttps://doi.org/10.1016/j.clim.2020.108591openalex-snapshot
On the genetics and immunopathogenesis of COVID-19
inferred← citeshttps://doi.org/10.1016/j.clim.2020.108598openalex-snapshot
Complement C3 vs C5 inhibition in severe COVID-19: Early clinical findings reveal differential biological efficacy
inferred← citeshttps://doi.org/10.1016/j.clim.2021.108716openalex-snapshot
Activation of classical and alternative complement pathways in the pathogenesis of lung injury in COVID-19
inferred← citeshttps://doi.org/10.1016/j.clim.2021.108726openalex-snapshot
Genetic justification of severe COVID-19 using a rigorous algorithm
inferred← citeshttps://doi.org/10.1016/j.clim.2026.110701openalex-snapshot
Post-acute sequelae of COVID-19: A disorder of impaired innate immune resolution – A narrative review
inferred← citeshttps://doi.org/10.1016/j.compbiomed.2021.104668openalex-snapshot
Identifying molecular insight of synergistic complexities for SARS-CoV-2 infection with pre-existing type 2 diabetes
inferred← citeshttps://doi.org/10.1016/j.critrevonc.2021.103529openalex-snapshot
COVID-19 and immunothrombosis: Pathophysiology and therapeutic implications
inferred← citeshttps://doi.org/10.1016/j.csbj.2023.02.002openalex-snapshot
Structural modelling of human complement FHR1 and two of its synthetic derivatives provides insight into their in-vivo functions
inferred← citeshttps://doi.org/10.1016/j.cyto.2020.155151openalex-snapshot
COVID-19 cytokine storm: The anger of inflammation
inferred← citeshttps://doi.org/10.1016/j.cytogfr.2020.10.002openalex-snapshot
Predictive monitoring and therapeutic immune biomarkers in the management of clinical complications of COVID-19
inferred← citeshttps://doi.org/10.1016/j.cytogfr.2020.12.001openalex-snapshot
The roles and potential therapeutic implications of C5a in the pathogenesis of COVID-19-associated coagulopathy
inferred← citeshttps://doi.org/10.1016/j.eclinm.2021.100831openalex-snapshot
Reduced Inflammatory Responses to SARS-CoV-2 Infection in Children Presenting to Hospital with COVID-19 in China
inferred← citeshttps://doi.org/10.1016/j.ejphar.2022.175267openalex-snapshot
Immunomodulatory role of Nanocurcumin in COVID-19 patients with dropped natural killer cells frequency and function
inferred← citeshttps://doi.org/10.1016/j.fct.2021.112007openalex-snapshot
Immunotoxic role of organophosphates: An unseen risk escalating SARS-CoV-2 pathogenicity
inferred← citeshttps://doi.org/10.1016/j.gendis.2025.101943openalex-snapshot
Dual-mode aptamer-driven biosensing platform for ultrasensitive and mutation-resilient detection of the SARS-CoV-2 nucleocapsid protein
inferred← citeshttps://doi.org/10.1016/j.heliyon.2020.e05877openalex-snapshot
Clinically distinct COVID-19 cases share notably similar immune response progression: A follow-up analysis
inferred← citeshttps://doi.org/10.1016/j.heliyon.2023.e17148openalex-snapshot
Multidimensional futuristic approaches to address the pandemics beyond COVID-19
inferred← citeshttps://doi.org/10.1016/j.humimm.2021.01.007openalex-snapshot
Pharmacological approach for the reduction of inflammatory and prothrombotic hyperactive state in COVID-19 positive patients by acting on complement cascade
inferred← citeshttps://doi.org/10.1016/j.ijbiomac.2024.129523openalex-snapshot
Overview of the SARS-CoV-2 nucleocapsid protein
inferred← citeshttps://doi.org/10.1016/j.ijid.2020.05.072openalex-snapshot
Three cases of treatment with nafamostat in elderly patients with COVID-19 pneumonia who need oxygen therapy
inferred← citeshttps://doi.org/10.1016/j.imbio.2020.152001openalex-snapshot
Endothelial injury and thrombotic microangiopathy in COVID-19: Treatment with the lectin-pathway inhibitor narsoplimab
inferred← citeshttps://doi.org/10.1016/j.imbio.2020.152008openalex-snapshot
Host-pathogen interaction in COVID-19: Pathogenesis, potential therapeutics and vaccination strategies
inferred← citeshttps://doi.org/10.1016/j.imbio.2023.152393openalex-snapshot
Complement and COVID-19: Three years on, what we know, what we don't know, and what we ought to know
inferred← citeshttps://doi.org/10.1016/j.immuni.2020.05.002openalex-snapshot
Immunology of COVID-19: Current State of the Science
inferred← citeshttps://doi.org/10.1016/j.intimp.2020.106980openalex-snapshot
Understanding the complexities of SARS-CoV2 infection and its immunology: A road to immune-based therapeutics
inferred← citeshttps://doi.org/10.1016/j.intimp.2020.107070openalex-snapshot
Decreased complement C3 levels are associated with poor prognosis in patients with COVID-19: A retrospective cohort study
inferred← citeshttps://doi.org/10.1016/j.intimp.2020.107082openalex-snapshot
Recent findings on the Coronavirus disease 2019 (COVID-19); immunopathogenesis and immunotherapeutics
inferred← citeshttps://doi.org/10.1016/j.intimp.2020.107364openalex-snapshot
Immunology, immunopathogenesis and immunotherapeutics of COVID-19; an overview
inferred← citeshttps://doi.org/10.1016/j.intimp.2021.107516openalex-snapshot
An overview of some potential immunotherapeutic options against COVID-19
inferred← citeshttps://doi.org/10.1016/j.intimp.2023.110081openalex-snapshot
The anaphylatoxin C5a: Structure, function, signaling, physiology, disease, and therapeutics
inferred← citeshttps://doi.org/10.1016/j.intimp.2025.115338openalex-snapshot
Preclinical evaluation of STSA-1002, a novel human and rhesus monkeys cross-reactive monoclonal antibody targeting C5a, in acute respiratory distress syndrome models
inferred← citeshttps://doi.org/10.1016/j.isci.2025.114233openalex-snapshot
SARS-CoV-2 nonstructural protein 1 suppresses host transcription by reducing RNA polymerase II levels
inferred← citeshttps://doi.org/10.1016/j.it.2020.12.002openalex-snapshot
Complement Factors in COVID-19 Therapeutics and Vaccines
inferred← citeshttps://doi.org/10.1016/j.jaci.2020.05.006openalex-snapshot
Complement activation in patients with COVID-19: A novel therapeutic target
inferred← citeshttps://doi.org/10.1016/j.jaci.2020.08.028openalex-snapshot
ARGX-117, a therapeutic complement inhibiting antibody targeting C2
inferred← citeshttps://doi.org/10.1016/j.jaci.2021.03.038openalex-snapshot
C5aR inhibition of nonimmune cells suppresses inflammation and maintains epithelial integrity in SARS-CoV-2–infected primary human airway epithelia
inferred← citeshttps://doi.org/10.1016/j.jaci.2021.11.004openalex-snapshot
Severe COVID-19 is associated with hyperactivation of the alternative complement pathway
inferred← citeshttps://doi.org/10.1016/j.jconrel.2021.07.028openalex-snapshot
Repurpose but also (nano)-reformulate! The potential role of nanomedicine in the battle against SARS-CoV2
inferred← citeshttps://doi.org/10.1016/j.kint.2020.05.013openalex-snapshot
The case of complement activation in COVID-19 multiorgan impact
inferred← citeshttps://doi.org/10.1016/j.lfs.2020.118431openalex-snapshot
SARS-CoV-2 and coagulation disorders in different organs
inferred← citeshttps://doi.org/10.1016/j.lfs.2021.119245openalex-snapshot
A double edged-sword - The Complement System during SARS-CoV-2 infection
inferred← citeshttps://doi.org/10.1016/j.lfs.2026.124625openalex-snapshot
SARS-CoV-2 nucleocapsid protein drives pulmonary injury by enhancing GRP75-dependent ER–mitochondria tethering and reprogramming of alveolar macrophages
inferred← citeshttps://doi.org/10.1016/j.matt.2021.02.025openalex-snapshot
Biomaterial-based immunoengineering to fight COVID-19 and infectious diseases
inferred← citeshttps://doi.org/10.1016/j.medj.2020.06.005openalex-snapshot
When Two Pandemics Meet: Why Is Obesity Associated with Increased COVID-19 Mortality?
inferred← citeshttps://doi.org/10.1016/j.medj.2024.01.011openalex-snapshot
Complement dysregulation is a prevalent and therapeutically amenable feature of long COVID
inferred← citeshttps://doi.org/10.1016/j.molimm.2022.08.008openalex-snapshot
Targeting thromboinflammation in COVID-19 – A narrative review of the potential of C1 inhibitor to prevent disease progression
inferred← citeshttps://doi.org/10.1016/j.molimm.2022.11.010openalex-snapshot
Antibody-Dependent Enhancement (ADE) and the role of complement system in disease pathogenesis
inferred← citeshttps://doi.org/10.1016/j.omtm.2023.101110openalex-snapshot
A T cell-targeted multi-antigen vaccine generates robust cellular and humoral immunity against SARS-CoV-2 infection
inferred← citeshttps://doi.org/10.1016/j.phymed.2025.156711openalex-snapshot
Xuanfei Baidu Formula confers protection against viral pneumonia by modulating CD8+ T cell proliferation via MAPK signalling pathway
inferred← citeshttps://doi.org/10.1016/j.prp.2021.153647openalex-snapshot
Host factors: Implications in immunopathogenesis of COVID-19
inferred← citeshttps://doi.org/10.1016/j.prp.2023.154519openalex-snapshot
Complement and complement regulatory proteins are upregulated in lungs of COVID-19 patients
inferred← citeshttps://doi.org/10.1016/j.pulmoe.2021.03.008openalex-snapshot
The immune response to SARS-CoV-2 and COVID-19 immunopathology – Current perspectives
inferred← citeshttps://doi.org/10.1016/j.rcreu.2021.02.013openalex-snapshot
COVID-19 coagulopathy and antiphospholipid syndrome
inferred← citeshttps://doi.org/10.1016/j.smim.2021.101533openalex-snapshot
Mutations of SARS-CoV-2 spike protein: Implications on immune evasion and vaccine-induced immunity
inferred← citeshttps://doi.org/10.1016/j.talanta.2022.123783openalex-snapshot
Electrochemical paper-based antigen sensing platform using plant-derived monoclonal antibody for detecting SARS-CoV-2
inferred← citeshttps://doi.org/10.1016/j.tcm.2020.12.004openalex-snapshot
COVID-19 and thrombosis: From bench to bedside
inferred← citeshttps://doi.org/10.1016/j.thromres.2020.06.027openalex-snapshot
Is COVID-19 associated thrombosis caused by overactivation of the complement cascade? A literature review
inferred← citeshttps://doi.org/10.1016/j.thromres.2020.06.029openalex-snapshot
The hypercoagulable state in COVID-19: Incidence, pathophysiology, and management
inferred← citeshttps://doi.org/10.1016/j.thromres.2020.08.039openalex-snapshot
COVID-19 and cardiovascular consequences: Is the endothelial dysfunction the hardest challenge?
inferred← citeshttps://doi.org/10.1016/j.thromres.2022.09.025openalex-snapshot
Tissue factor in COVID-19-associated coagulopathy
inferred← citeshttps://doi.org/10.1016/j.tice.2021.101497openalex-snapshot
Clinically relevant cell culture models and their significance in isolation, pathogenesis, vaccine development, repurposing and screening of new drugs for SARS-CoV-2: a systematic review
inferred← citeshttps://doi.org/10.1016/j.trsl.2020.11.008openalex-snapshot
The role of the lectin pathway of the complement system in SARS-CoV-2 lung injury
inferred← citeshttps://doi.org/10.1016/j.tru.2022.100126openalex-snapshot
Therapeutic considerations for prevention and treatment of thrombotic events in COVID-19
inferred← citeshttps://doi.org/10.1016/j.vph.2021.106829openalex-snapshot
Endothelial cells and SARS-CoV-2: An intimate relationship
inferred← citeshttps://doi.org/10.1016/j.waojou.2020.100454openalex-snapshot
Does hereditary angioedema make COVID-19 worse?
inferred← citeshttps://doi.org/10.1016/j.xcrm.2022.100811openalex-snapshot
Nucleocapsid-specific antibody function is associated with therapeutic benefits from COVID-19 convalescent plasma therapy
inferred← citeshttps://doi.org/10.1016/j.yjmcc.2020.07.003openalex-snapshot
Coagulopathy in COVID-19: Focus on vascular thrombotic events
inferred← citeshttps://doi.org/10.1016/j.ymthe.2022.02.014openalex-snapshot
The battle between host and SARS-CoV-2: Innate immunity and viral evasion strategies
inferred← citeshttps://doi.org/10.1016/s2665-9913(20)30341-6openalex-snapshot
Anti-C5a antibody IFX-1 (vilobelimab) treatment versus best supportive care for patients with severe COVID-19 (PANAMO): an exploratory, open-label, phase 2 randomised controlled trial
inferred← citeshttps://doi.org/10.1016/s2665-9913(20)30420-3openalex-snapshot
COVID-19 vasculitis and novel vasculitis mimics
inferred← citeshttps://doi.org/10.1021/acsbiomaterials.0c01287openalex-snapshot
Biomaterials-Based Opportunities to Engineer the Pulmonary Host Immune Response in COVID-19
inferred← citeshttps://doi.org/10.1021/acschembio.2c00114openalex-snapshot
Directed Evolution-Driven Increase of Structural Plasticity Is a Prerequisite for Binding the Complement Lectin Pathway Blocking MASP-Inhibitor Peptides
inferred← citeshttps://doi.org/10.1038/s41392-022-01043-6openalex-snapshot
Cell deaths: Involvement in the pathogenesis and intervention therapy of COVID-19
inferred← citeshttps://doi.org/10.1038/s41392-025-02220-zopenalex-snapshot
The immune system in cardiovascular diseases: from basic mechanisms to therapeutic implications
inferred← citeshttps://doi.org/10.1038/s41467-021-23036-9openalex-snapshot
A SARS-CoV-2 antibody curbs viral nucleocapsid protein-induced complement hyperactivation
inferred← citeshttps://doi.org/10.1038/s41564-020-00789-5openalex-snapshot
Antibody-dependent enhancement and SARS-CoV-2 vaccines and therapies
inferred← citeshttps://doi.org/10.1038/s41569-021-00640-2openalex-snapshot
Potential long-term effects of SARS-CoV-2 infection on the pulmonary vasculature: a global perspective
inferred← citeshttps://doi.org/10.1038/s41577-020-00470-2openalex-snapshot
Leukocyte trafficking to the lungs and beyond: lessons from influenza for COVID-19
inferred← citeshttps://doi.org/10.1038/s41577-020-0314-5openalex-snapshot
Coronaviruses hijack the complement system
inferred← citeshttps://doi.org/10.1038/s41577-020-0320-7openalex-snapshot
Complement as a target in COVID-19?
inferred← citeshttps://doi.org/10.1038/s41577-020-0359-5openalex-snapshot
Dissecting antibody-mediated protection against SARS-CoV-2
inferred← citeshttps://doi.org/10.1038/s41577-021-00634-8openalex-snapshot
Crosstalk between the renin–angiotensin, complement and kallikrein–kinin systems in inflammation
inferred← citeshttps://doi.org/10.1038/s41577-021-00665-1openalex-snapshot
The state of complement in COVID-19
inferred← citeshttps://doi.org/10.1038/s41581-020-00357-4openalex-snapshot
Immunity, endothelial injury and complement-induced coagulopathy in COVID-19
inferred← citeshttps://doi.org/10.1038/s41584-020-0474-5openalex-snapshot
Emerging evidence of a COVID-19 thrombotic syndrome has treatment implications
inferred← citeshttps://doi.org/10.1038/s41586-020-2600-6openalex-snapshot
Association of COVID-19 inflammation with activation of the C5a–C5aR1 axis
inferred← citeshttps://doi.org/10.1038/s41587-021-01020-4openalex-snapshot
Integrated analysis of plasma and single immune cells uncovers metabolic changes in individuals with COVID-19
inferred← citeshttps://doi.org/10.1038/s41590-020-00849-2openalex-snapshot
Does tissue imprinting restrict macrophage plasticity?
inferred← citeshttps://doi.org/10.1038/s41598-021-83108-0openalex-snapshot
Role of IgG against N-protein of SARS-CoV2 in COVID19 clinical outcomes
inferred← citeshttps://doi.org/10.1038/s41598-021-86002-xopenalex-snapshot
Comprehensive transcriptomic analysis of COVID-19 blood, lung, and airway
inferred← citeshttps://doi.org/10.1038/s41598-021-90797-0openalex-snapshot
Targeting of the CD80/86 proinflammatory axis as a therapeutic strategy to prevent severe COVID-19
inferred← citeshttps://doi.org/10.1038/s41598-022-12242-0openalex-snapshot
Structure-guided affinity maturation of a novel human antibody targeting the SARS-CoV-2 nucleocapsid protein
inferred← citeshttps://doi.org/10.1038/s41598-022-15225-3openalex-snapshot
A structural homology approach to identify potential cross-reactive antibody responses following SARS-CoV-2 infection
inferred← citeshttps://doi.org/10.1038/s41598-022-17334-5openalex-snapshot
Humoral and cellular response in convalescent COVID-19 lupus patients
inferred← citeshttps://doi.org/10.1038/s41598-024-76365-2openalex-snapshot
Complement activation and lung injury in Japanese patients with COVID-19: a prospective observational study
inferred← citeshttps://doi.org/10.1038/s41598-026-37866-4openalex-snapshot
SARS-CoV-2 nucleocapsid protein forms complexes with soluble complement regulatory proteins that can bind to the virion
inferred← citeshttps://doi.org/10.1038/s41598-026-40984-8openalex-snapshot
SARS-CoV-2 nucleocapsid protein-specific monoclonal antibodies as tools for studying its antigenic structure and interaction with host cells
inferred← citeshttps://doi.org/10.1038/s42003-022-03094-5openalex-snapshot
A synthetic protein as efficient multitarget regulator against complement over-activation
inferred← citeshttps://doi.org/10.1038/s42003-025-08648-xopenalex-snapshot
Structural basis of a human antibody targeting SARS-CoV-2 nucleocapsid protein dimerization domain and interfering with RNA-binding
inferred← citeshttps://doi.org/10.1038/s44318-024-00061-0openalex-snapshot
Control of complement-induced inflammatory responses to SARS-CoV-2 infection by anti-SARS-CoV-2 antibodies
inferred← citeshttps://doi.org/10.1039/d3na00342fopenalex-snapshot
Post COVID-19 complications and follow up biomarkers
inferred← citeshttps://doi.org/10.1042/bsr20211491openalex-snapshot
Targeting intra-viral conserved nucleocapsid (N) proteins as novel vaccines against SARS-CoVs
inferred← citeshttps://doi.org/10.1051/medsci/2021021openalex-snapshot
Implication de la cascade du complément dans les formes sévères de COVID-19
inferred← citeshttps://doi.org/10.1055/s-0040-1718532openalex-snapshot
Venous Thromboembolism in COVID-19
inferred← citeshttps://doi.org/10.1073/pnas.2010540117openalex-snapshot
Systemic complement activation is associated with respiratory failure in COVID-19 hospitalized patients
inferred← citeshttps://doi.org/10.1073/pnas.2521209122openalex-snapshot
Glycan recognition by collectin-11 drives SARS-CoV-2 infectivity and membrane injury of respiratory epithelial cells
inferred← citeshttps://doi.org/10.1074/mcp.ra120.002295openalex-snapshot
Site-specific N-glycosylation Characterization of Recombinant SARS-CoV-2 Spike Proteins
inferred← citeshttps://doi.org/10.1080/07391102.2020.1820381openalex-snapshot
Binding of raloxifene to human complement fragment 5a ( h C5a): a perspective on cytokine storm and COVID19
inferred← citeshttps://doi.org/10.1080/08830185.2020.1800688openalex-snapshot
Emerging Human Coronavirus Infections (SARS, MERS, and COVID-19): Where They Are Leading Us
inferred← citeshttps://doi.org/10.1080/08830185.2020.1840566openalex-snapshot
Pathogenesis Guided Therapeutic Management of COVID-19: An Immunological Perspective
inferred← citeshttps://doi.org/10.1080/08830185.2020.1840567openalex-snapshot
How could we forget immunometabolism in SARS-CoV2 infection or COVID-19?
inferred← citeshttps://doi.org/10.1080/14712598.2023.2235269openalex-snapshot
Optimizing the use of vilobelimab for the treatment of COVID-19
inferred← citeshttps://doi.org/10.1080/14728222.2022.2031975openalex-snapshot
Ramatroban for chemoprophylaxis and treatment of COVID-19: David takes on Goliath
inferred← citeshttps://doi.org/10.1080/14760584.2022.2081156openalex-snapshot
The chimera of S1 and N proteins of SARS-CoV-2: can it be a potential vaccine candidate for COVID-19?
inferred← citeshttps://doi.org/10.1080/14787210.2022.2150165openalex-snapshot
The efficacy and safety of complement C5a inhibitors for patients with severe COVID-19: a systematic review and meta-analysis
inferred← citeshttps://doi.org/10.1080/1744666x.2021.1847084openalex-snapshot
Coronavirus disease 2019: investigational therapies in the prevention and treatment of hyperinflammation
inferred← citeshttps://doi.org/10.1080/21505594.2021.1898790openalex-snapshot
Immune dysregulation and system pathology in COVID-19
inferred← citeshttps://doi.org/10.1080/21548331.2021.2007648openalex-snapshot
Anticoagulation in COVID-19: a review of current literature and guidelines
inferred← citeshttps://doi.org/10.1080/22221751.2022.2164219openalex-snapshot
The role of SARS-CoV-2 nucleocapsid protein in antiviral immunity and vaccine development
inferred← citeshttps://doi.org/10.1080/22221751.2025.2467781openalex-snapshot
SARS-CoV-2 enhances complement-mediated endothelial injury via the suppression of membrane complement regulatory proteins
inferred← citeshttps://doi.org/10.1080/23744235.2020.1769853openalex-snapshot
Mechanistic inferences from clinical reports of SARS-CoV-2
inferred← citeshttps://doi.org/10.1083/jcb.202404131openalex-snapshot
SARS-CoV-2 specific adaptations in N protein inhibit NF-κB activation and alter pathogenesis
inferred← citeshttps://doi.org/10.1084/jem.20201439openalex-snapshot
Neutrophils and COVID-19: Nots, NETs, and knots
inferred← citeshttps://doi.org/10.1093/ckj/sfaa166openalex-snapshot
Eculizumab, SARS-CoV-2 and atypical hemolytic uremic syndrome
inferred← citeshttps://doi.org/10.1093/ckj/sfaa192openalex-snapshot
Temporal changes in complement activation in haemodialysis patients with COVID-19 as a predictor of disease progression
inferred← citeshttps://doi.org/10.1093/femspd/ftaa026openalex-snapshot
The pathological autopsy of coronavirus disease 2019 (COVID-2019) in China: a review
showing the first 200 of 438
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.